<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">IODOQUINOL</span><br/>(eye-oh-do-kwin'ole)<br/><span class="topboxtradename">Diiodohydroxyquin, </span><span class="topboxtradename">Dioquinol, </span><span class="topboxtradename">Sebaquin, </span><span class="topboxtradename">Yodoxin<br/></span><b>Classifications:</b> <span class="classification">antiinfective</span>; <span class="classification">amebicide</span>; <span class="classification">antiprotozoal</span><br/><b>Prototype: </b>Emetine<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>210 mg, 650 mg tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Direct-acting (contact) amebicide.</p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Effective against both trophozoites and cyst forms of <i>Entamoeba histolytica</i> in intestinal lumen. Not useful for extraintestinal amebiasis. Range of antiprotozoal action includes <i>Trichomonas vaginalis</i> and <i>Balantidium coli;</i> also has some antibacterial and antifungal properties.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Intestinal amebiasis and for asymptomatic passers of cysts. Commonly used either concurrently or in alternating courses with
         another intestinal amebicide.
      </p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p> <i>Balantidiasis</i> and <i>Acrodermatitis enteropathica;</i> traveler's diarrhea; shampoo preparation (Sebaquin) used for control of seborrheic dermatitis of scalp.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to any 8-hydroxyquinoline or to iodine-containing preparations or foods; hepatic or renal damage; preexisting
         optic neuropathy. Safe use during pregnancy (category C) or lactation is not established.
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Severe thyroid disease; minor self-limiting problems; prolonged high-dosage therapy.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Intestinal Amebiasis</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 630650 mg t.i.d. for 20 d (max: 2 g/d); may repeat after a 23 wk drug-free interval<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> 3040 mg/kg/d in 23 divided doses for 20 d (max: 1.95 g/d); may repeat after a 23 wk drug-free interval<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give drug after meals. If patient has difficulty swallowing tablet, crush and mix with applesauce.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> Hypersensitivity (urticaria, pruritus). <span class="typehead">CNS:</span> Headache, agitation, retrograde amnesia, vertigo, ataxia, peripheral neuropathy (especially in children); muscle pain, weakness
      usually below T<sub>12</sub> vertebrae, dysesthesias especially of lower limbs, paresthesias, increased sense of warmth. <span class="typehead">Special Senses:</span> Blurred vision, <span class="speceff-life">optic atrophy</span>, optic neuritis, <span class="speceff-life">permanent loss of vision</span>. <span class="typehead">GI:</span> Nausea, vomiting, anorexia, abdominal cramps, diarrhea, constipation, rectal irritation and itching. <span class="typehead">Skin:</span> Discoloration of hair and nails, acne, hair loss, urticaria, various forms of skin eruptions. <span class="typehead">Hematologic:</span> <span class="speceff-life">Agranulocytosis</span> (rare). <span class="typehead">Endocrine:</span> Thyroid hypertrophy, iodism [generalized furunculosis (iodine toxiderma), skin eruptions, fever, chills, weakness]. 
      <h1><a name="dtintefer">Diagnostic Test Interference</a></h1>
<p>Iodoquinol can cause elevations of <span class="alt">PBI</span> and decrease of <span class="alt">I-131 uptake</span> (effects may last for several weeks to 6 mo even after discontinuation of therapy). <span class="alt">Ferric chloride test for PKU</span> (phenylketonuria) may yield false-positive results if iodoquinol is present in urine.
      </p>
<h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Small amount absorbed from GI tract. <span class="typehead">Elimination:</span> Excreted in feces. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor I&amp;O ratio. Record characteristics of stools: color, consistency, frequency, presence of blood, mucus, or other material.</li>
<li> 							Note: ophthalmologic examinations are recommended at regular intervals during prolonged therapy. 						</li>
<li>Monitor and report immediately the onset of blurred or decreased vision or eye pain. Also report symptoms of peripheral neuropathy:
            pain, numbness, tingling, or weakness of extremities.
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Report skin rash and symptoms of agranulocytosis (see Appendix F).</li>
<li>Complete full course of treatment. Stool needs be examined again 1, 3, and 6 mo after termination of treatment.</li>
<li> 							Note: Intestinal amebiasis is spread mainly by contaminated water, raw fruits or vegetables, flies, roaches, and hand-to-mouth transfer
            of infected feces. It is very important to wash hands after defecation and before eating. 						
         </li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>